Related Experiment Video

Updated: Aug 23, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

CD40 and vascular inflammation

Carmen Urbich1, Stefanie Dimmeler

  • 1Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany.

The Canadian Journal of Cardiology
|June 16, 2004
PubMed

Insights

The CD40/CD40L system is crucial in atherosclerosis, a chronic inflammatory disease. Inhibiting this interaction prevents plaque buildup, offering new therapeutic strategies for cardiovascular conditions.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Metabolic Disorders

Background:

  • Atherosclerosis is a chronic inflammatory disease involving lipid metabolism and endothelial dysfunction.
  • Risk factors and cytokines contribute to endothelial activation, promoting an adhesive and dysfunctional state.
  • The CD40 receptor and CD40 ligand system are key regulators of immune responses.

Purpose of the Study:

  • To investigate the role of the CD40/CD40L system in the pathophysiology of atherosclerosis.
  • To explore the potential of targeting the CD40/CD40L interaction for therapeutic interventions.

Main Methods:

  • Review of existing studies on CD40/CD40L in atherosclerosis.
  • Analysis of animal models demonstrating the impact of CD40/CD40L inhibition on atherogenesis.

Main Results:

  • The CD40/CD40L system plays a significant role in cellular immunity, inflammation, and atherosclerosis development.
  • Inhibition of CD40/CD40L interaction has been shown to prevent atherogenesis in preclinical models.

Conclusions:

  • The CD40/CD40L pathway is a critical factor in atherosclerotic plaque formation.
  • Targeting CD40L presents a promising therapeutic avenue for treating atherosclerosis and related inflammatory disorders.

More Related Videos

Generation of Human CD40-activated B cells13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inflammation01:38

Inflammation

Overview
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...